Global venture funding totaled $26 billion in January, with healthcare and AI again emerging as the top sectors for startup investment, 91¾«Æ·...
Health, Wellness & Biotech
The remote work trend might see a resurgence, but it won’t come without hurdles, writes guest author Rajat Mishra of Prezent AI. He provides three...
As shares of Boston-based Vertex shot higher on the news of its non-opioid pill, Journavx, we took a look at investment in startups focused on pain...
The year started strong for huge rounds, as the first month saw a trio of billion-dollar raises and a slew of others of more than $250 million...
While the year started out hot for large megaround deals, it has slowed considerably. Just three startups raised nine-figure rounds this week and you...
Although global venture funding rose overall in 2024, it wasn’t a particularly strong year for emerging economies. Even so, there were a few...
While the fourth quarter showed a little resilience — bouncing back after a slow Q3 — the Asia venture market has proven a bumpy, if not entirely...
After a frenetic first couple of weeks as far as big rounds go, this week was quieter than a library. Only one round of more than $100 million was...
While last year wasn’t the cascade of M&A activity many had wished for (and certainly the IPO pipeline never unfroze), it did provide some hope. Deal...
Thus far 2025 has come roaring in as far as large rounds go. Last week more than a dozen companies raised $100 million or more. This week there are...
Colossal Biosciences, a de-extinction startup looking at ways to bring back the dodo bird and the woolly mammoth, raised a $200 million Series C at a...


67.1K Followers